96
Participants
Start Date
January 2, 2025
Primary Completion Date
September 30, 2026
Study Completion Date
September 30, 2026
Nanosensor
"The purpose of the study is to test a device called a nanosensor, which measures oxygen levels (a proxy of mitochondrial function) in muscle. The nanosensor has not been tested in humans nor has it been approved by the FDA. The study nanosensor measures 1.8 mm width x 6 mm length x 0.3 mm depth. Placement of the sterilized nanosensor involves a small incision for manual placement of the nanosensor in muscle forearm tissue."
RECRUITING
The Children's Hospital of Philadelphia, Philadelphia
United States Department of Defense
FED
Children's Hospital of Philadelphia
OTHER